Doc's Attys Duel Over Fee Split In $785M Pfizer FCA Deal
By Dani Kass ( January 8, 2018, 8:35 PM EST) -- Three firms that represented a whistleblower in a False Claims Act suit against a Pfizer subsidiary on Monday set the stage for an upcoming civil trial over fees with briefs disputing whether two firms that were fired eight years before the case settled for $785 million should be entitled to a large chunk of the winnings....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.